Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.23M Sell
6,342
-185
-3% -$66K 0.81% 36
2025
Q4
$2.14M Sell
6,527
-819
-11% -$260K 0.78% 39
2025
Q3
$2.07M Sell
7,346
-56
-0.8% -$16.2K 0.76% 41
2025
Q2
$2.07M Buy
7,402
+267
+4% +$75.6K 0.81% 35
2025
Q1
$2.22M Buy
7,135
+119
+2% +$35.1K 0.92% 34
2024
Q4
$1.83M Buy
7,016
+454
+7% +$135K 0.75% 37
2024
Q3
$2.11M Buy
6,562
+194
+3% +$63.5K 0.86% 29
2024
Q2
$1.99M Buy
6,368
+440
+7% +$129K 0.96% 29
2024
Q1
$1.69M Buy
5,928
+855
+17% +$250K 0.72% 40
2023
Q4
$1.46M Buy
+5,073
New +$1.38M 0.62% 46

Other funds holding AMGN

BKM Wealth Management's AMGN Position: Q1 2026 in Review

BKM Wealth Management reduced its Amgen (AMGN) stake by 2.8% in Q1 2026, selling an estimated $66K and leaving 6,342 shares worth $2.23M. The position accounts for 0.81% of the portfolio, ranked #36.

BKM Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • BKM Wealth Management held 6,342 shares of Amgen worth $2.23M as of Q1 2026.
  • BKM Wealth Management sold 185 Amgen shares in Q1 2026, an estimated $66K.
  • Amgen made up 0.81% of BKM Wealth Management's portfolio in Q1 2026, its #36 holding.
  • BKM Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BKM Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.